This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by MALLETTE, L. E. Articles by MALINI, S. Search for Related Content PubMed PubMed Citation Articles by MALLETTE, L. E. Articles by MALINI, S.

Lithium Treatment Increases Intact and Midregion Parathyroid Hormone and Parathyroid Volume^*

Section of Endocrinology and Metabolism, Veterans Administration Medical Center Houston, Texas 77030
The Departments of Psychiatry and Internal Medicine Baylor College of Medicine Houston, Texas 77030
The Department of Pediatrics, Medical University of South Carolina Charleston, South Carolina 29425

Address requests for reprints to: Dr. Mallette, Medical Service 111 E. Veterans Administration Medical Center, 2002 Holcombe Boulevard, Houston, Texas 77030.

Lithium carbonate is known to alter calcium metabolism by lowering urinary calcium excretion and increasing serum calcium concentrations. Several investigators have reported increases in serum immunoreactive PTH (iPTH) values after a few weeks or months of lithium treatment, and several cases of primary hyperparathyroidism developing during lithium treatment have been reported. To determine whether the increases in serum iPTH might be the result of increased renal retention of inactive PTH fragments rather than stimulation of parathyroid function, we measured plasma intact PTH by im-munoradiometric assay and estimated parathyroid size by ultra-sonography in men who had received short term (<6 months) or long term (>3 yr) lithium treatment and in normal subjects. Serum ionized calcium was higher by 0.03–0.04 mmol/L in subjects treated short term (mean, 1.7 months) with lithium than in normal subjects, but plasma intact PTH and serum midregion iPTH values were not different. The absence of a reciprocal decrease in PTH values is compatible with a lithium-induced shift in the set-point for the inhibition of PTH secretion by calcium toward a higher calcium value. Both plasma intact PTH and serum midregion PTH values were higher in subjects during longer term (mean, 103 months) lithium treatment, and estimated parathyroid volume was 3-fold higher. Serum phosphate was lower, and serum chloride and plasma 1,25-dihydroxy-vitamin D values were higher in those treated with lithium long term, probably from the biological action of the increased PTH. We conclude that long term lithium treatment increases circulating biologically active PTH and causes parathyroid enlargement. Whether this chronic stimulus to parathyroid growth might lead to adenoma formation in certain susceptible individuals and whether a PTH-induced increase in skeletal remodelling occurs that might hasten the appearance of osteopenia remain to be determined.

^* This work was supported by the V.A.

Received August 26, 1988.

This article has been cited by other articles:

				Severe symptomatic hypercalcaemia Postgrad. Med. J., October 1, 2000; 76(900): 663c - 663. [Full Text]

				R Gama, J Wright, and G Ferns An unusual case of hypercalcaemia Postgrad. Med. J., December 1, 1999; 75(890): 769 - 770. [Full Text]

				S. T. Haden, A. L. Stoll, S. McCormick, J. Scott, and G. El-Hajj Fuleihan Alterations in Parathyroid Dynamics in Lithium-Treated Subjects J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2844 - 2848. [Abstract] [Full Text] [PDF]

				E. M. Brown and A. L. Vickery Case 32-1996- A 44-Year-Old Woman with a Long History of Intermittent Hypercalcemia, a New Neck Mass, and Hypercalcemic Crisis N. Engl. J. Med., October 17, 1996; 335(16): 1213 - 1220. [Full Text] [PDF]